bioRxiv Science⌕ Search

bioRxiv · 10.1101/2024.05.31.596825

Integrating Data Across Oscillatory Power Bands Predicts the Epileptogenic Zone: the Frequency Range Explorer Epileptogenic Zone (FREEZ) Identification Algorithm

Abstract

Accurate identification of the seizure onset zone (SOZ) using intracranial electroencephalography (iEEG) remains challenging. Although diverse methods have leveraged spectral features to classify patient outcomes, few approaches focus on identifying individual electrodes within the SOZ or integrate a broad spectrum of frequency ranges within a single model. We developed an interpretable machine learning model that integrates power across delta, theta, alpha, beta, gamma, and high-gamma frequencies over time to identify the SOZ. For 1,511 electrodes implanted across 21 patients, we computed the mean spectral power in each frequency band for the first 20 seconds after seizure onset and analyzed the differences in power between SOZ and non-SOZ electrodes. In patients who were seizure-free after surgery (n = 14), electrodes within the SOZ showed significantly higher area under the curve (AUC) for mean power over time in the first 20 seconds after seizure onset compared to electrodes outside the SOZ in the alpha (p = 0.0272), beta (p = 0.0263), gamma (p = 0.0013), and high gamma (p = 0.0086) ranges. Additionally, electrodes within the SOZ in patients that became seizure-free after surgery had significantly higher AUC compared to equivalent electrodes in patients who did not become seizure-free after surgery (n = 7) in the gamma (p = 0.0145) and high gamma (p = 0.0024) power ranges. We trained a stacked random forest ensemble model using these features over time to label electrodes within the SOZ. Leave-one-out patient cross validation of the machine learning model yielded a 96.6% positive predictive value and 99.9% specificity for identifying electrodes within the SOZ. Our dataset included a diverse array of seizure onset patterns, which were all classified accurately by the model. A second model was trained to predict post-operative seizure freedom, yielding 95.2% accuracy for predicting seizure outcome based on a planned resection. This two-model design mirrors clinical workflow, first localizing SOZ electrodes to support surgical planning, then predicting outcome based on a surgical plan. An advantage of our interpretable machine learning approach is the ability to interrogate our models to understand how predictions are made. For electrode classification, the model weighed beta (0.66 {+/-} 0.07), high gamma (0.54 {+/-} 0.06), and delta (0.51 {+/-} 0.06) power bands most heavily. Viewing the models frequency band weights over time reveals that the model identified a pattern resembling the "fingerprint of the epileptogenic zone", reinforcing the importance of this dominant fundamental neurophysiologic signature of seizure onset.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

O'Leary, S., Lesage, A.-C., Camarillo-Rodriguez, L., Zhou, O., Silveira, D., Wang, J., Sheth, S., Beauchamp, M. S., Wang, Z., Magnotti, J. F., Karas, P. J.. 2024-06-01. Integrating Data Across Oscillatory Power Bands Predicts the Epileptogenic Zone: the Frequency Range Explorer Epileptogenic Zone (FREEZ) Identification Algorithm. https://doi.org/10.1101/2024.05.31.596825

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗